Patients with clinically isolated syndromes suggestive of MS
Does MRI allow earlier diagnosis?
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Patients presenting with clinically isolated syndromes (CIS) compatible with MS create a diagnostic and therapeutic dilemma. Although some CIS are self-limited and do not require long-term treatment, others are the first clinical manifestation of MS, where, in light of recent studies,1,2⇓ one would consider starting disease-modifying therapies.3 However, identifying which patients have MS has been difficult. Until recently, clinicians used diagnostic criteria developed by Schumacher et al.4 in 1965 based on physical examination findings alone; these criteria were modified in 1983 by Poser et al.5 to include evoked response testing and CSF examination. This meant that diagnosis of MS could not be made until at least two clinical events occurred.4 With the advent of MRI, it has been shown that over 80% of patients with CIS and MRI lesions go on to be diagnosed with MS, whereas approximately 20% have self-limited processes.6 In July 2001, the International Panel on MS Diagnosis, chaired by Ian McDonald, made recommendations that built on older diagnostic criteria by incorporating MRI findings.7 The recommendations included criteria for determining whether lesions on brain MRI are abnormal and whether these abnormalities satisfy the criteria for dissemination in time and space. The outcome of a diagnostic evaluation has been simplified to “MS,” “possible MS,” or “not MS.” These criteria now allow a diagnosis of MS to be made in a patient presenting …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.